South Korean Government To Build New Flu Vaccine Plant As Part Of Campaign For "Vaccine Independence" From Global Giants
This article was originally published in PharmAsia News
Executive Summary
SEOUL - To avoid a recurrence of last year's challenge to secure flu vaccines during the A/H1N1 pandemic, South Korea's government has initiated a drive to bolster the nation's independent capacity to produce these vaccines
You may also be interested in...
Novavax Eyes Asia Expansion As Vaccines Portfolio Progresses
The U.S. vaccines company Novavax is making inroads into Asia and developing markets with its influenza and RSV vaccines.
Novavax Eyes Asia Expansion As Vaccines Portfolio Progresses
The U.S. vaccines company Novavax is making inroads into Asia and developing markets with its influenza and RSV vaccines.
South Korea Starts Onsite Inspections Of Essential Drug Reserves Amid Tension With North Korea
As tensions between South and North Korea simmer, South Korea is conducting its first on-site inspections of drug reserves since 2006.